R
Redhill Biopharma Ltd D
D
RDHL
0.92000
USD
-0.01
(-1.08%)
مغلق
حجم التداول
362
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,775,959
المقالات
العنوان: Redhill Biopharma Ltd
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
